FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100035207> ?p ?o ?g. }

• W2100035207 endingPage "3021" @default.
• W2100035207 startingPage "3015" @default.
• W2100035207 abstract "Background: Colorectal cancer (CRC) is a major cause of mortality in developed countries, and it is the third most frequent malignancy in Turkey. There are many biological, genetic, molecular, and tissue-derived prognostic factors for CRCs. In this study, we evaluated prognostic factors in patients who were metastatic at diagnosis or progressed to metastatic disease during follow-up. Patients and Methods: This study included 116 patients with malignancies either in the colon or rectum. Of these, 65 had metastatic disease at diagnosis, and 51 progressed to metastatic disease during the course of the disease. The parameters evaluated were age, gender, comorbidity, performance status and stage of the disease at the beginning, localization, history of surgery, chemotherapy regimen, response to first-line treatment, K-RAS status, site and number of metastases, expression of tumor predictors (CEA, CA19-9), and survival times. A multivariate analysis conducted with factors that considered statistically significant in the univariate analysis. Findings: Median age was 56 (32-82) years and the male/female ratio was 80/36. Eleven patients were at stage II, 40 at stage III, and 65 at stage IV at diagnosis. Twenty three patients had tumor in the right colon, 48 in the left colon, and 45 in the rectum. Ninety seven patients were operated, and 27 had surgical metastasectomy. Ninety three patients received targeted therapy. At the end of follow-up, 61 patients had died, and 55 survived. Metastatic period survival times were longer in the adjuvant group, but the difference did not reach the level of statistical significance (adjuvant group: median 29 months, metastatic group: median 22 months; p=0.285). In the adjuvant group before the metastatic first-line therapy, CEA and CA 19-9 levels were significiantly lower compared to the metastatic group (p<0.005). We also found that patients with elevated tumor predictor (CEA, CA 19-9) levels before the first-line therapy had significiantly poorer prognosis and shorter survival time. Survival was significiantly better with the patients who were younger than 65 years of age, had better initial performance status, a history of primary surgery and metastatectomy, and single site of metastasis. Those who benefitted from the first-line therapy were K-RAS wild type and whose tumor markers (CEA, CA 19-9) were not elevated before the first line therapy. Conclusions: Among the patients with metastatic CRC, those who benefited from first-line therapy, had history of metastasectomy, were K-RAS wild type and had low CA 19-9 levels before the first-line therapy, showed better prognosis independent of other factors." @default.
• W2100035207 created "2016-06-24" @default.
• W2100035207 creator A5008706516 @default.
• W2100035207 creator A5017404018 @default.
• W2100035207 creator A5023268545 @default.
• W2100035207 creator A5037670666 @default.
• W2100035207 creator A5044883162 @default.
• W2100035207 creator A5080580069 @default.
• W2100035207 creator A5085709455 @default.
• W2100035207 creator A5086747983 @default.
• W2100035207 date "2015-04-14" @default.
• W2100035207 modified "2023-10-13" @default.
• W2100035207 title "Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients" @default.
• W2100035207 cites W112820751 @default.
• W2100035207 cites W1586939666 @default.
• W2100035207 cites W1969745958 @default.
• W2100035207 cites W1985213644 @default.
• W2100035207 cites W1986897680 @default.
• W2100035207 cites W2025280540 @default.
• W2100035207 cites W2031973084 @default.
• W2100035207 cites W2036045525 @default.
• W2100035207 cites W2053270575 @default.
• W2100035207 cites W2057668520 @default.
• W2100035207 cites W2058681003 @default.
• W2100035207 cites W2072935816 @default.
• W2100035207 cites W2076116834 @default.
• W2100035207 cites W2083168840 @default.
• W2100035207 cites W2090222968 @default.
• W2100035207 cites W2094697691 @default.
• W2100035207 cites W2095201384 @default.
• W2100035207 cites W2101431916 @default.
• W2100035207 cites W2102205534 @default.
• W2100035207 cites W2119943104 @default.
• W2100035207 cites W2124292749 @default.
• W2100035207 cites W2125447919 @default.
• W2100035207 cites W2128937038 @default.
• W2100035207 cites W2129627582 @default.
• W2100035207 cites W2133399075 @default.
• W2100035207 cites W2141483786 @default.
• W2100035207 cites W2141986829 @default.
• W2100035207 cites W2143743735 @default.
• W2100035207 cites W2146442025 @default.
• W2100035207 cites W2149710756 @default.
• W2100035207 cites W2155311724 @default.
• W2100035207 cites W2157769714 @default.
• W2100035207 cites W2171253554 @default.
• W2100035207 cites W2598363796 @default.
• W2100035207 doi "https://doi.org/10.7314/apjcp.2015.16.7.3015" @default.
• W2100035207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25854399" @default.
• W2100035207 hasPublicationYear "2015" @default.
• W2100035207 type Work @default.
• W2100035207 sameAs 2100035207 @default.
• W2100035207 citedByCount "20" @default.
• W2100035207 countsByYear W21000352072015 @default.
• W2100035207 countsByYear W21000352072016 @default.
• W2100035207 countsByYear W21000352072018 @default.
• W2100035207 countsByYear W21000352072019 @default.
• W2100035207 countsByYear W21000352072020 @default.
• W2100035207 countsByYear W21000352072021 @default.
• W2100035207 countsByYear W21000352072022 @default.
• W2100035207 countsByYear W21000352072023 @default.
• W2100035207 crossrefType "journal-article" @default.
• W2100035207 hasAuthorship W2100035207A5008706516 @default.
• W2100035207 hasAuthorship W2100035207A5017404018 @default.
• W2100035207 hasAuthorship W2100035207A5023268545 @default.
• W2100035207 hasAuthorship W2100035207A5037670666 @default.
• W2100035207 hasAuthorship W2100035207A5044883162 @default.
• W2100035207 hasAuthorship W2100035207A5080580069 @default.
• W2100035207 hasAuthorship W2100035207A5085709455 @default.
• W2100035207 hasAuthorship W2100035207A5086747983 @default.
• W2100035207 hasBestOaLocation W21000352071 @default.
• W2100035207 hasConcept C121608353 @default.
• W2100035207 hasConcept C126322002 @default.
• W2100035207 hasConcept C143998085 @default.
• W2100035207 hasConcept C144301174 @default.
• W2100035207 hasConcept C146357865 @default.
• W2100035207 hasConcept C151730666 @default.
• W2100035207 hasConcept C2776907518 @default.
• W2100035207 hasConcept C2778601017 @default.
• W2100035207 hasConcept C2779134260 @default.
• W2100035207 hasConcept C2779399171 @default.
• W2100035207 hasConcept C2781074409 @default.
• W2100035207 hasConcept C2781413609 @default.
• W2100035207 hasConcept C38180746 @default.
• W2100035207 hasConcept C526805850 @default.
• W2100035207 hasConcept C71924100 @default.
• W2100035207 hasConcept C86803240 @default.
• W2100035207 hasConcept C90924648 @default.
• W2100035207 hasConceptScore W2100035207C121608353 @default.
• W2100035207 hasConceptScore W2100035207C126322002 @default.
• W2100035207 hasConceptScore W2100035207C143998085 @default.
• W2100035207 hasConceptScore W2100035207C144301174 @default.
• W2100035207 hasConceptScore W2100035207C146357865 @default.
• W2100035207 hasConceptScore W2100035207C151730666 @default.
• W2100035207 hasConceptScore W2100035207C2776907518 @default.
• W2100035207 hasConceptScore W2100035207C2778601017 @default.
• W2100035207 hasConceptScore W2100035207C2779134260 @default.
• W2100035207 hasConceptScore W2100035207C2779399171 @default.

• next